合并症对初次择期关节置换术医疗费用的影响
该回顾性研究纳入2015年1月至2016年7月单中心1258例接受初次择期全关节置换术的Medicare患者,评估14种合并症对医疗费用的影响。多元线性回归显示,心律失常、瓣膜性心脏病和贫血显著增加住院费用;神经系统疾病、恶性肿瘤、高血压、抑郁和甲状腺功能减退与急性后期护理费用增加相关;神经系统疾病、高血压、恶性肿瘤和糖尿病是全流程费用的预测因素。作者认为合并症负担越重,费用越高,可用于未来支付方式的风险分层。
要点
- 心律失常、瓣膜性心脏病和贫血与初次择期全关节置换术住院费用增加显著相关。
- 神经系统疾病、恶性肿瘤、高血压、抑郁和甲状腺功能减退与急性后期护理费用增加相关。
- 神经系统疾病、高血压、恶性肿瘤和糖尿病是全流程费用增加的预测因素。
核心结论
- 初次择期全关节置换术患者的医疗费用随合并症增多而增加,特定疾病对费用的影响可为未来支付方式的风险分层提供参考。
研究设计与样本
- 回顾性研究纳入2015年1月至2016年7月单中心1258例接受初次择期全关节置换术的Medicare患者,其中男性488例,髋关节552例,平均年龄71岁,费用数据来自美国医疗保险和医疗补助服务中心,合并症信息来自病历人工审查,最终多元线性回归模型纳入14种合并症。
主要发现
- 回归模型可显著预测费用变异(P < .001)。
- 住院费用方面,心律失常(P < .001)、瓣膜性心脏病(P = .014)和贫血(P = .020)显著增加费用。
- 急性后期护理费用方面,帕金森病或癫痫等神经系统疾病(P < .001)、恶性肿瘤(P = .001)、高血压(P = .012)、抑郁(P = .014)和甲状腺功能减退(P = .044)与费用增加相关。
- 全流程费用方面,神经系统疾病(P < .001)、高血压(P = .012)、恶性肿瘤(P = .023)和糖尿病(P = .029)是费用增加的预测因素。
临床怎么用
- 作者认为这些数据可为未来支付方式中的风险分层提供参考。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Comprehensive Care for Joint Replacement model is the newest iteration of the bundled payment methodology introduced by the Centers for Medicare and Medicaid Services. Comprehensive Care for Joint Replacement model, while incentivizing providers to deliver care at a lower cost, does not incorporate any patient-level risk stratification. Our study evaluated the impact of specific medical co-morbidities on the cost of care in total joint arthroplasty (TJA) patients. METHODS: A retrospective study was conducted on 1258 Medicare patients who underwent primary elective TJA between January 2015 and July 2016 at a single institution. There were 488 males, 552 hips, and the mean age was 71 years. Cost data were obtained from the Centers for Medicare and Medicaid Services. Co-morbidity information was obtained from a manual review of patient records. Fourteen co-morbidities were included in our final multiple linear regression models. RESULTS: The regression models significantly predicted cost variation (P < .001). For index hospital costs, a history of cardiac arrhythmias (P < .001), valvular heart disease (P = .014), and anemia (P = .020) significantly increased costs. For post-acute care costs, a history of neurological conditions like Parkinson's disease or seizures (P < .001), malignancy (P = .001), hypertension (P = .012), depression (P = .014), and hypothyroidism (P = .044) were associated with increases in cost. Similarly, for total episode cost, a history of neurological conditions (P < .001), hypertension (P = .012), malignancy (P = .023), and diabetes (P = .029) were predictors for increased costs. CONCLUSION: The cost of care in primary elective TJA increases with greater patient co-morbidity. Our data provide insight into the relative impact of specific medical conditions on cost of care and may be used in risk stratification in future reimbursement methodologies.
引用
- Penna S, Bell KL, Kuo FC, et al. Impact of Co-Morbidities on the Cost of Care in Primary Elective Joint Arthroplasty. J Arthroplasty. 2019. PMID: 30777622. doi:10.1016/j.arth.2019.01.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。